Brazil's health regulatory agency approves sale of first marijuana-based product
Cannabidiol compound oil may be sold in pharmacies, with a special control recipe
Thursday, April 23, 2020
Brazil's National Health Surveillance Agency (Anvisa) approved the registration of the first cannabis-based product in the country. Cannabidiol oil may be sold in pharmacies only with a special prescription provided by local health surveillance. This is the first registration granted by the agency since the agency approved a regulation that opens space for the sale of cannabis-based products in these locations, based on some criteria. The agency created a new category of plant-based products, different from the one used for medicines. The product is a phytopharmaceutical based on cannabidiol. This component of cannabis has a therapeutic effect on some conditions. (See also: Brazil approves first medical cannabis product under 2019 regulations)
